Month: April 2026

Millicom (Tigo) strengthens its position in Colombia following the successful acquisition of the government stake in Coltel This milestone enhances scale and investment capacity to strengthen network capabilities and support future growth in Colombia. Luxembourg, April 27, 2026 – Millicom International Cellular S.A. (“Millicom”) today announced it has acquired the remaining 32.5% equity stake in Colombia Telecomunicaciones S.A. E.S.P. (“Coltel”) formerly held by La Nación. This milestone follows the successful conclusion of the tender offer for Telefónica’s controlling stake in February 2026 and marks the final step in Millicom’s strategic consolidation of the entity. The acquisition represents a decisive moment for the Colombian telecommunications sector. By integrating Coltel fully into its operations, Millicom...

IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time). A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the event. About Beta Bionics Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES MONTRÉAL, April 27, 2026 (GLOBE NEWSWIRE) — Morocco Strategic Minerals Corporation. (TSXV: MCC) (“MCC” or the “Corporation”) is pleased to announce that, as a result of strong investor demand, it has increased the maximum gross proceeds of its previously announced non-brokered private placement from $5,000,000 to $7,500,000 (the “Offering”). The upsized Offering now consists of the sale of up to 50,000,000 units of the Corporation (“Units”) at a price of $0.15 per Unit. For more information about the Offering, please refer to the Corporation’s news release dated April 20, 2026. Each Unit will consist of (i) one common share in the capital of the Corporation (a “Common Share”) and (ii) one half of one Common Share purchase...

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2026 on Thursday, May 14, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE’s Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio...

SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company’s Investor Relations website here. About Trupanion Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, and certain countries in Continental Europe with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet’s recovery, not financial stress. Trupanion is committed to providing pet parents with the highest value in pet medical insurance with unlimited payouts on eligible expenses for the life of their pets. With its patented process, Trupanion is the...

The Shelf Prospectus is accessible, and the Supplement will be accessible within two business days, under the Company’s issuer profile on SEDAR+. TORONTO, April 27, 2026 (GLOBE NEWSWIRE) — Blue Moon Metals Inc. (“Blue Moon” or the “Company“) (TSXV: MOON; NASDAQ: BMM), is pleased to announce its board of directors has approved a final investment decision on the construction for its Nussir project (“Project”), located in northern Norway. The recent Feasibility Study on the Project announced on April 16, 2026, highlighted a 13-year mine life with a nominal 6,000 tonne per day underground mine and processing facility with ore production starting in Q3-2027. Furthermore, recently announced exploration success at the Project (see release dated April 15, 2026), highlights the potential upside and longevity...

MENLO PARK, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications, today announced that it has commenced an underwritten public offering of $500 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Oruka expects to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of its common stock at the public offering price, less underwriting discounts and commissions. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering...

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — VisionSys AI Inc. (NASDAQ: VSA) (“VSA” or the “Company”) today announced that it is in advanced discussions with a strategic investor regarding a proposed strategic investment. Based on the terms currently under discussion, the investor plans to invest a total of $90 million in VSA at a price of $1.50 per share. This proposed investment represents a key step forward for VSA in capital formation, strategic collaboration, and business transformation. The Company is currently focused on advancing its Brain-Computer Interface (“BCI”) business by leveraging its core algorithms and related software and hardware systems, while accelerating the development of AI-powered healthcare and biotechnology solutions. The Company believes that this potential investment could provide meaningful support...